findmyKOL

James Figge, MD

Basic profile

Trinity Health

ORCIDNone on fileNPI
RegionFort Myers, FL · SoutheastSpecialtyEndocrinology, Diabetes & MetabolismFocusEndocrinology/Metabolic
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2021Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

James Figge is an Endocrinology/Metabolic physician affiliated with Trinity Health. OpenAlex indexes 77 publications with 4,320 citations (h-index 30).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
77publications

Distinct works indexed by OpenAlex.

4,320citations

Total citations across indexed works.

30h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
37companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

8960 Colonial Center Dr Ste 202
Fort Myers, FL 339057810

Telephone

239-343-9646

Provider last certified this registry record 6 Oct 2023.

View the NPPES registry record

Industry payments

37 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Metabolism & gastrointestinal

    66.8%
    GLP-1 receptor agonist30.4%
    Mounjaro47%Ozempic31%Trulicity22%
    Part D71 patients
    Insulin Analog21.4%
    Lantus Solostar21%Tresiba Flextouch U-20011%Novolog Flexpen10%Toujeo Solostar10%Humalog Kwikpen U-1009%Tresiba Flextouch U-1009%Humalog7%Basaglar Kwikpen U-1007%Fiasp Flextouch5%Lantus4%Insulin Lispro Kwikpen U-1004%Novolog3%
    Part D<11 patients

    + 4 more classes in this area

  • Hormonal (systemic)

    26.8%
    l-Thyroxine21.8%
    Levothyroxine Sodium82%Synthroid19%
    Part D147 patients
    l-Triiodothyronine3%
    Liothyronine Sodium100%
    Part D27 patients

    + 1 more class in this area

  • Sensory organs

    2.7%
    Corticosteroid2.7%
    Hydrocortisone64%Dexamethasone36%
    Part D<11 patients
Where care is delivered (Part B)0% facility · 100% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”